PUBLISH YOUR EVENTS!
Boston Professional Events List
Please wait...
13TH ANNUAL CMHC
Date
Oct 26, 2021 - 08:00 AM
Organizer
CMHC
Location
Boston Sheraton Hotel39 Dalton St.,
Boston, ,
MA,
US,
ZIP: 02199
Phone:
13TH ANNUAL CMHC
Wednesday, October 24, 2020
More than one-third of the population has at least one cardiometabolic risk factor - dyslipidemia, CVD, hypertension, diabetes, and/or obesity. Now in its 13th year, the Cardiometabolic Health Congress is the largest, US-based, multidisciplinary conference focused solely on the management of cardiometabolic risk and the prevention of cardiovascular and metabolic disease. The 3 ½- day event offers today's busy healthcare professionals a one-of-a-kind opportunity to learn real-world solutions they can integrate immediately into their clinical practices.
Session topics include:
Risk Factors for Dyslipidemia, Atherosclerosis, and Cardiovascular Disease
The Effect of Circadian Rhythm on Obesity and CVD
Diet Quality, Quantity, and Beyond in Cardiometabolic Disorders
Insulin and Non-Insulin Therapies for Diabetes Management
Challenging Patient Cases in Hypertension, Cardio-renal, and Heart Failure
EARN 21+
CME CREDIT HOURS
WOMEN'S HEALTH SUMMIT: CARDIOMETABOLIC HEALTH ACROSS THE LIFESPAN
10:30 - 10:40 am
Introduction to CMHC Women's Health Summit
Pamela B. Morris, MD
10:40 - 11:10 am
Cardio-oncology: An emerging field
Ana Barac, MD
11:10 - 11:40 am
The Intersection Between Breast Cancer and Cardiovascular Disease
Ana Barac, MD
11:40 - 11:55 am
Interactive Participant Q&A Session
Ana Barac, MD
12:00 - 1:00 pm
PME Lunch Symposium (Non-CME)
Sponsored by Amgen, Inc.
1:10 - 1:15 pm
Welcome Back to Women’s Health Summit
Pamela B. Morris, MD
1:15 - 1:45 pm
Cardiometabolic Risk in PCOS and Implications for Management
Andrea E. Dunaif, MD
1:45 - 2:15 pm
Impact of Pregnancy on CV Risk Factors and ASCVD Risk
Pam R. Taub, MD
2:15 - 2:30 pm
Nutrition Break
2:30 - 3:00 pm
Choosing Wisely: Contraception in Women with Cardiometabolic Risk
Nieca Goldberg, MD
3:00 - 3:30 pm
Updates on the Role of Postmenopausal Hormone Replacement Therapy
JoAnn E. Manson, MD, DrPH, FAHA
3:30 - 3:50 pm
Women’s Health Summit Expert Panel Discussion and Q&A
Chair:Pamela B. Morris, MD
Panelists: Andrea E. Dunaif, MD
Pam R. Taub, MD
JoAnn E. Manson, MD, DrPH, FAHA
3:50 - 4:00 pm
Conclusions to CMHC Women’s Health Summit
Pamela B. Morris, MD
4:15 - 5:15 pm
PME Light Bites Session (Non-CME)
Sponsored by the American Society for Preventive Cardiology
5:30 - 6:30 pm
PME Light Bites Session (Non-CME)
Serge Jabbour, MD
Sponsored by Janssen Pharmaceuticals, Inc.
6:45 - 7:45 pm
PME Dinner Symposium (Non-CME)
Sponsored by Amarin Pharma, Inc.
Thursday, October 25, 2020 CMHC GENERAL SESSIONS
Session I: Diabetes Management
6:30 - 7:45 am
CME Breakfast Symposium
The Role of CGM in Individualization of T2DM Management
Chair: Anne L. Peters, MD
Presenter: Irl B. Hirsch, MD
Supported in part by an educational grant from Dexcom, Inc..
7:55 - 8:00 am
Opening Remarks
Jay S. Skyler, MD
8:00 - 9:30 am
FDA Update and Late Breaking Clinical Trials
Chair:Christie M. Ballantyne, MD
Panelists:Robert H. Eckel, MD
Jay S. Skyler, MD
Keith C. Ferdinand, MD
Deepak L. Bhatt, MD, MPH
9:30 - 10:15 am
KEYNOTE
C. Ronald Kahn, MD
10:15 - 11:15 am
Morning Break - Exhibit Hall
11:15 am - 12:00 pm
So Many Options - Dispelling the Confusion About Insulins
Irl B. Hirsch, MD
12:10 - 1:25 pm
CME Lunch Symposium A
Management of T2DM Patients with Diabetic Kidney Disease: Effects of SGLT2 Inhibitors and GLP1 Receptor Agonists on Disease Progression
Chair: Matt Weir, MD
Presenters: Lance Sloan, MD; Robert D. Toto, MD
Supported by educational grants from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC. and by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC
12:10 - 1:25 pm
CME Lunch Symposium B
Advances in HFpEF: Addressing Diagnostic and Treatment Challenges
Chair: JoAnn Lindenfeld, MD
Presenters: Keith C. Ferdinand, MD; Alanna A. Morris, MD
Supported by an educational grant from Novartis Pharmaceuticals Corporation.
1:35 - 2:20 pm
Where Are We with Devices for Diabetes Management?
Anne L. Peters, MD
2:20 - 3:20 pm
Afternoon Break - Exhibit Hall
3:20 - 3:50 pm
How Many GLP1 RAs Do We Need and Why?
John B. Buse, MD
3:50 - 5:05 pm
Multidisciplinary Case Consults
Chair:Jay S. Skyler, MD
Panelists: John B. Buse, MD
Robert H. Eckel, MD
Davida F. Kruger, MSN, APNBC, BCADM
Anne L. Peters, MD
Irl B. Hirsch, MD
5:10 - 6:10 pm
Welcome Reception - Exhibit Hall
6:20 - 7:35 pm
CME Dinner Symposium
Mastering the Prior Authorization Process to Meet Patient Needs
Chair: Pamela B. Morris, MD
Presenters: Christie M. Ballantyne, MD; Kim K. Birtcher, PharmD
Supported by an educational grant from Sanofi US and Regeneron Pharmaceuticals.
7:40 - 8:40 pm
PME Dinner Symposium (Non-CME)
Sponsored by Akcea Therapeutics
Friday, October 26, 2020 CMHC GENERAL SESSIONS
Session II: Obesity and Lifestyle Management in Cardiovascular Disease
6:30 - 7:45 am
CME Breakfast Symposium
The ABC Access Program: Overcoming Barriers to Access of Newer Cardiovascular Agents for High-Risk and Minority Patients
Chair: Keith C. Ferdinand, MD
Faculty: Deirdre Mattina, MD; Catherine Davis Ahmed, MBA
Supported by an educational funding donation provided by Amgen and in partnership with the Association of Black Cardiologists, Inc (ABC).
7:55 - 8:00 am
Opening Remarks
Robert H. Eckel, MD
8:00 - 8:45 am
Heart Healthy Nutrition
Stephen Devries, MD
8:45 - 9:15 am
Updates on the Microbiome and Metabolic Surgery
Mary-Elizabeth Patti, MD
9:15 - 10:15 am
Morning Break - Exhibit Hall
10:15 - 11:00 am
Obesity and Environmental Influence: The Big Picture
James O. Hill, PhD
11:00 - 11:45 am
Day to Day Management of Obesity in Clinical Practice
Robert F. Kushner, MD
11:45 - 11:50 am
Closing Remarks
Robert H. Eckel, MD
12:00 - 1:15 pm
CME Lunch Symposium
Identifying, Diagnosing and Managing Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life
Presenters: Biykem Bozkurt, MD; Gurushner Panjrath, MD
Supported by an educational grant from American Regent.
Session III: Dyslipidemia, Atherosclerosis, and Cardiovascular Disease Risk Reduction
1:25 - 1:30 pm
Opening Remarks
Christie M. Ballantyne, MD
1:30 - 2:20 pm
Targeting Inflammation: Updates on Pathophysiology and Clinical Outcomes
Peter Libby, MD;
Paul M. Ridker, MD
This session is supported by an educational grant from Novartis Pharmaceuticals Corporation.
2:20 - 3:20 pm
Afternoon Break - Exhibit Hall
3:20 - 4:10 pm
How Aggressively Do We Lower LDL-C and for Which Patients?
Vera A. Bittner, MD, MSPH;
Marc S. Sabatine, MD, MPH
4:10 - 5:00 pm
Risk Assessment for Global Cardiovascular Disease: Imaging and Biomarkers
Matthew J. Budoff, MD;
James de Lemos, MD
5:00 - 6:00 pm
Multidisciplinary Case Consults
Chair:Christie M. Ballantyne, MD
Panelists: Robert H. Eckel, MD
Pamela B. Morris, MD
Margo B. Minissian, PhD, ACNP
Pam R. Taub, MD
Vera A. Bittner, MD, MSPH
This session is supported by educational grants from Amarin Pharma, Inc and Akcea Therapeutics.
6:00 - 6:05 pm
Closing Remarks
Christie M. Ballantyne, MD
6:05 - 7:05 pm
Closing Reception - Exhibit Hall
7:15 - 8:15 pm
PME Dinner Symposium (Non-CME)
Sponsored by Novo Nordisk
Saturday, October 27, 2020 CMHC GENERAL SESSIONS
Session IV: Hypertension, Cardio-renal, and Heart Failure
6:30 - 7:45 am
CME Breakfast Symposium
7:55 - 8:00 am
Opening Remarks
George L. Bakris, MD
8:00 - 9:00 am
Overview of the New 2020 Hypertension Clinical Practice Guidelines
George L. Bakris, MD
9:00 - 9:30 am
Comparing the Hypertension Guidelines - Where is the Equipoise?
William B. White, MD
9:30 - 9:45 am
Nutrition Break
9:45 - 10:45 am
Patient Cases: How would you change the management of hypertension based on the new guidelines?
Aldo Peixoto, MD; William B. White, MD; Keith C. Ferdinand, MD
10:45 - 11:15 am
Prevention of Heart Failure: The Next Frontier
Clyde W. Yancy, MD
11:15 - 11:25 am
Mini Break
11:25 - 11:55 am
Integration of Biomarkers and Prediction of AKI and Cardio-renal Outcomes in Clinical Practice
Aldo Peixoto, MD
11:55 am - 12:25 pm
AKI and Heart Failure: How to manage compared to general population?
Peter A. McCullough, MD
12:25 - 12:55 pm
Advanced CKD and Benefits From CVOTs
Jorge Plutzky, MD
12:55 - 1:00 pm
Closing Remarks
JOA180514CEV
Wednesday, October 24, 2020
More than one-third of the population has at least one cardiometabolic risk factor - dyslipidemia, CVD, hypertension, diabetes, and/or obesity. Now in its 13th year, the Cardiometabolic Health Congress is the largest, US-based, multidisciplinary conference focused solely on the management of cardiometabolic risk and the prevention of cardiovascular and metabolic disease. The 3 ½- day event offers today's busy healthcare professionals a one-of-a-kind opportunity to learn real-world solutions they can integrate immediately into their clinical practices.
Session topics include:
Risk Factors for Dyslipidemia, Atherosclerosis, and Cardiovascular Disease
The Effect of Circadian Rhythm on Obesity and CVD
Diet Quality, Quantity, and Beyond in Cardiometabolic Disorders
Insulin and Non-Insulin Therapies for Diabetes Management
Challenging Patient Cases in Hypertension, Cardio-renal, and Heart Failure
EARN 21+
CME CREDIT HOURS
WOMEN'S HEALTH SUMMIT: CARDIOMETABOLIC HEALTH ACROSS THE LIFESPAN
10:30 - 10:40 am
Introduction to CMHC Women's Health Summit
Pamela B. Morris, MD
10:40 - 11:10 am
Cardio-oncology: An emerging field
Ana Barac, MD
11:10 - 11:40 am
The Intersection Between Breast Cancer and Cardiovascular Disease
Ana Barac, MD
11:40 - 11:55 am
Interactive Participant Q&A Session
Ana Barac, MD
12:00 - 1:00 pm
PME Lunch Symposium (Non-CME)
Sponsored by Amgen, Inc.
1:10 - 1:15 pm
Welcome Back to Women’s Health Summit
Pamela B. Morris, MD
1:15 - 1:45 pm
Cardiometabolic Risk in PCOS and Implications for Management
Andrea E. Dunaif, MD
1:45 - 2:15 pm
Impact of Pregnancy on CV Risk Factors and ASCVD Risk
Pam R. Taub, MD
2:15 - 2:30 pm
Nutrition Break
2:30 - 3:00 pm
Choosing Wisely: Contraception in Women with Cardiometabolic Risk
Nieca Goldberg, MD
3:00 - 3:30 pm
Updates on the Role of Postmenopausal Hormone Replacement Therapy
JoAnn E. Manson, MD, DrPH, FAHA
3:30 - 3:50 pm
Women’s Health Summit Expert Panel Discussion and Q&A
Chair:Pamela B. Morris, MD
Panelists: Andrea E. Dunaif, MD
Pam R. Taub, MD
JoAnn E. Manson, MD, DrPH, FAHA
3:50 - 4:00 pm
Conclusions to CMHC Women’s Health Summit
Pamela B. Morris, MD
4:15 - 5:15 pm
PME Light Bites Session (Non-CME)
Sponsored by the American Society for Preventive Cardiology
5:30 - 6:30 pm
PME Light Bites Session (Non-CME)
Serge Jabbour, MD
Sponsored by Janssen Pharmaceuticals, Inc.
6:45 - 7:45 pm
PME Dinner Symposium (Non-CME)
Sponsored by Amarin Pharma, Inc.
Thursday, October 25, 2020 CMHC GENERAL SESSIONS
Session I: Diabetes Management
6:30 - 7:45 am
CME Breakfast Symposium
The Role of CGM in Individualization of T2DM Management
Chair: Anne L. Peters, MD
Presenter: Irl B. Hirsch, MD
Supported in part by an educational grant from Dexcom, Inc..
7:55 - 8:00 am
Opening Remarks
Jay S. Skyler, MD
8:00 - 9:30 am
FDA Update and Late Breaking Clinical Trials
Chair:Christie M. Ballantyne, MD
Panelists:Robert H. Eckel, MD
Jay S. Skyler, MD
Keith C. Ferdinand, MD
Deepak L. Bhatt, MD, MPH
9:30 - 10:15 am
KEYNOTE
C. Ronald Kahn, MD
10:15 - 11:15 am
Morning Break - Exhibit Hall
11:15 am - 12:00 pm
So Many Options - Dispelling the Confusion About Insulins
Irl B. Hirsch, MD
12:10 - 1:25 pm
CME Lunch Symposium A
Management of T2DM Patients with Diabetic Kidney Disease: Effects of SGLT2 Inhibitors and GLP1 Receptor Agonists on Disease Progression
Chair: Matt Weir, MD
Presenters: Lance Sloan, MD; Robert D. Toto, MD
Supported by educational grants from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC. and by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC
12:10 - 1:25 pm
CME Lunch Symposium B
Advances in HFpEF: Addressing Diagnostic and Treatment Challenges
Chair: JoAnn Lindenfeld, MD
Presenters: Keith C. Ferdinand, MD; Alanna A. Morris, MD
Supported by an educational grant from Novartis Pharmaceuticals Corporation.
1:35 - 2:20 pm
Where Are We with Devices for Diabetes Management?
Anne L. Peters, MD
2:20 - 3:20 pm
Afternoon Break - Exhibit Hall
3:20 - 3:50 pm
How Many GLP1 RAs Do We Need and Why?
John B. Buse, MD
3:50 - 5:05 pm
Multidisciplinary Case Consults
Chair:Jay S. Skyler, MD
Panelists: John B. Buse, MD
Robert H. Eckel, MD
Davida F. Kruger, MSN, APNBC, BCADM
Anne L. Peters, MD
Irl B. Hirsch, MD
5:10 - 6:10 pm
Welcome Reception - Exhibit Hall
6:20 - 7:35 pm
CME Dinner Symposium
Mastering the Prior Authorization Process to Meet Patient Needs
Chair: Pamela B. Morris, MD
Presenters: Christie M. Ballantyne, MD; Kim K. Birtcher, PharmD
Supported by an educational grant from Sanofi US and Regeneron Pharmaceuticals.
7:40 - 8:40 pm
PME Dinner Symposium (Non-CME)
Sponsored by Akcea Therapeutics
Friday, October 26, 2020 CMHC GENERAL SESSIONS
Session II: Obesity and Lifestyle Management in Cardiovascular Disease
6:30 - 7:45 am
CME Breakfast Symposium
The ABC Access Program: Overcoming Barriers to Access of Newer Cardiovascular Agents for High-Risk and Minority Patients
Chair: Keith C. Ferdinand, MD
Faculty: Deirdre Mattina, MD; Catherine Davis Ahmed, MBA
Supported by an educational funding donation provided by Amgen and in partnership with the Association of Black Cardiologists, Inc (ABC).
7:55 - 8:00 am
Opening Remarks
Robert H. Eckel, MD
8:00 - 8:45 am
Heart Healthy Nutrition
Stephen Devries, MD
8:45 - 9:15 am
Updates on the Microbiome and Metabolic Surgery
Mary-Elizabeth Patti, MD
9:15 - 10:15 am
Morning Break - Exhibit Hall
10:15 - 11:00 am
Obesity and Environmental Influence: The Big Picture
James O. Hill, PhD
11:00 - 11:45 am
Day to Day Management of Obesity in Clinical Practice
Robert F. Kushner, MD
11:45 - 11:50 am
Closing Remarks
Robert H. Eckel, MD
12:00 - 1:15 pm
CME Lunch Symposium
Identifying, Diagnosing and Managing Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life
Presenters: Biykem Bozkurt, MD; Gurushner Panjrath, MD
Supported by an educational grant from American Regent.
Session III: Dyslipidemia, Atherosclerosis, and Cardiovascular Disease Risk Reduction
1:25 - 1:30 pm
Opening Remarks
Christie M. Ballantyne, MD
1:30 - 2:20 pm
Targeting Inflammation: Updates on Pathophysiology and Clinical Outcomes
Peter Libby, MD;
Paul M. Ridker, MD
This session is supported by an educational grant from Novartis Pharmaceuticals Corporation.
2:20 - 3:20 pm
Afternoon Break - Exhibit Hall
3:20 - 4:10 pm
How Aggressively Do We Lower LDL-C and for Which Patients?
Vera A. Bittner, MD, MSPH;
Marc S. Sabatine, MD, MPH
4:10 - 5:00 pm
Risk Assessment for Global Cardiovascular Disease: Imaging and Biomarkers
Matthew J. Budoff, MD;
James de Lemos, MD
5:00 - 6:00 pm
Multidisciplinary Case Consults
Chair:Christie M. Ballantyne, MD
Panelists: Robert H. Eckel, MD
Pamela B. Morris, MD
Margo B. Minissian, PhD, ACNP
Pam R. Taub, MD
Vera A. Bittner, MD, MSPH
This session is supported by educational grants from Amarin Pharma, Inc and Akcea Therapeutics.
6:00 - 6:05 pm
Closing Remarks
Christie M. Ballantyne, MD
6:05 - 7:05 pm
Closing Reception - Exhibit Hall
7:15 - 8:15 pm
PME Dinner Symposium (Non-CME)
Sponsored by Novo Nordisk
Saturday, October 27, 2020 CMHC GENERAL SESSIONS
Session IV: Hypertension, Cardio-renal, and Heart Failure
6:30 - 7:45 am
CME Breakfast Symposium
7:55 - 8:00 am
Opening Remarks
George L. Bakris, MD
8:00 - 9:00 am
Overview of the New 2020 Hypertension Clinical Practice Guidelines
George L. Bakris, MD
9:00 - 9:30 am
Comparing the Hypertension Guidelines - Where is the Equipoise?
William B. White, MD
9:30 - 9:45 am
Nutrition Break
9:45 - 10:45 am
Patient Cases: How would you change the management of hypertension based on the new guidelines?
Aldo Peixoto, MD; William B. White, MD; Keith C. Ferdinand, MD
10:45 - 11:15 am
Prevention of Heart Failure: The Next Frontier
Clyde W. Yancy, MD
11:15 - 11:25 am
Mini Break
11:25 - 11:55 am
Integration of Biomarkers and Prediction of AKI and Cardio-renal Outcomes in Clinical Practice
Aldo Peixoto, MD
11:55 am - 12:25 pm
AKI and Heart Failure: How to manage compared to general population?
Peter A. McCullough, MD
12:25 - 12:55 pm
Advanced CKD and Benefits From CVOTs
Jorge Plutzky, MD
12:55 - 1:00 pm
Closing Remarks
JOA180514CEV